Socioeconomic Disparities Are Associated With Delayed Access to Tafamidis in Transthyretin Cardiac Amyloidosis

被引:0
|
作者
Miller, Peter [1 ,2 ]
Elias, Pierre [1 ,3 ]
Einstein, Andrew J. [1 ,2 ,4 ]
Maurer, Mathew S. [1 ,2 ]
Ahmed, Gasmelseed Y. [2 ]
Poterucha, Timothy J. [1 ,2 ]
机构
[1] Columbia Univ, NewYork Presbyterian Hosp, Irving Med Ctr, Dept Med, 177 Ft Washington Ave,Milstein 2, New York, NY 10032 USA
[2] Columbia Univ, NewYork Presbyterian Hosp, Irving Med Ctr, Dept Med,Seymour Paul & Gloria Milstein Div Cardio, New York, NY USA
[3] Columbia Univ, NewYork Presbyterian Hosp, Irving Med Ctr, Dept Biomed Informat, New York, NY USA
[4] Columbia Univ, NewYork Presbyterian Hosp, Irving Med Ctr, Dept Radiol, New York, NY USA
关键词
cardiac amyloidosis; socioeconomic disparities; tafamidis; transthyretin;
D O I
10.1161/CIRCHEARTFAILURE.124.012075
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis
    Waddington Cruz M.
    Benson M.D.
    Neurology and Therapy, 2015, 4 (2) : 61 - 79
  • [32] A Comprehensive Review on Chemistry and Biology of Tafamidis in Transthyretin Amyloidosis
    Patil, Monali B.
    Ghode, Piyush
    Joshi, Prashant
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024, 24 (06) : 571 - 587
  • [33] BLEEDING RISK ASSOCIATED WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS
    Bukhari, Syed
    Fatima, Shumail
    Nieves, Ricardo
    Ibrahim, Joseph
    Brownell, Amy
    Soman, Prem
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 530 - 530
  • [34] Clinical outcomes for 2788 patients with transthyretin amyloidosis:Tafamidis meglumine early access program in France
    Lairez, Olivier
    Reant, Patricia
    Inamo, Jocelyn
    Jeanneteau, Julien
    Bauer, Fabrice
    Habib, Gilbert
    Eicher, Jean-Christophe
    Lequeux, Benoit
    Legallois, Damien
    Josse, Constant
    Hippocrate, Aurelie
    Bartoli, Mathilde
    Dubois, Margaux
    Cosson, Charlotte Noirot
    Squara, Pierre-Alexandre
    Fievez, Stephane
    Quinault, Aurore
    Rudant, Jeremie
    Kharoubi, Mounira
    Damy, Thibaud
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2025, 118 (02) : 123 - 132
  • [35] A NEW TRANSTHYRETIN VARIANT ASSOCIATED WITH CARDIAC AMYLOIDOSIS
    ALMEIDA, MR
    HESSE, A
    STEINMETZ, A
    MAISCH, R
    ALTLAND, K
    LINKE, AP
    GAWINOWICZ, MA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 181 - 181
  • [36] Hereditary cardiac amyloidosis associated with transthyretin mutation
    Strazar, Z. Dolenc
    Lafitic-Jasnic, D.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 203 - 204
  • [37] Functional Class, Biomarker Stability, and Clinical Outcomes of Patients With Transthyretin Cardiac Amyloidosis Treated With Tafamidis
    Chandrashekar, Pranav
    Dale, Zack
    Rashdan, Lana
    Elman, Miriam
    Nazer, Babak
    Heitner, Stephen B.
    Masri, Ahmad
    CIRCULATION, 2020, 142
  • [38] Socioeconomic Deprivation And The Severity Of Newly Diagnosed Transthyretin Cardiac Amyloidosis: Is There A Link?
    Fahed, Gracia
    Jimenez, John isaiah
    Fonseca, Marina I. Adrianzen
    Spencer-bonilla, Gabriella
    Haddad, Francois
    Witteles, Ronald M.
    Alexander, Kevin M.
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (01)
  • [39] Transthyretin cardiac amyloidosis
    Manganiello, Carlos F.
    MEDICINA-BUENOS AIRES, 2020, 80 (04) : 388 - 388
  • [40] Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review
    Cruz, Marcia Waddington
    CLINICAL AUTONOMIC RESEARCH, 2019, 29 (Suppl 1) : 19 - 24